Biogen Exec Says Expecting Growth From Apellis Acquisition Even Without The Pipeline; Our Ambition Is Over The Next Few Years To Have At Least 20 Programs In Early Stage Development
https://event.webcasts.com/viewer/event.jsp?ei=1771787&tp_key=52bcd10df0
Share
Why It Matters
Biogen bought a company called Apellis and plans to grow it. They want to build many new medicines over the next few years.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.